Common questions about BO-SE (FAQ)
Q: What is the main purpose of BO-SE injection?
According to the official product information, the main purpose of BO-SE is indicated for the prevention and treatment of White Muscle Disease (Selenium-Tocopherol Deficiency) syndrome. It is indicated for use in calves, lambs, and ewes for this condition.
Q: What specific conditions is BO-SE recommended to prevent and treat?
BO-SE is specifically recommended for conditions associated with Selenium-Tocopherol Deficiency. For sows and weanling pigs, official documents indicate it is an aid in preventing and treating associated diseases such as hepatic necrosis, mulberry heart disease, and white muscle disease.
Q: Which animal species is BO-SE specifically indicated for use in?
Official documents indicate the product is specifically for use in calves, lambs, ewes, sows, and weanling pigs.
Q: What is Selenium-Tocopherol Deficiency, which BO-SE is designed to address?
The official pharmacology section describes this deficiency syndrome as the target condition. Selenium and Vitamin E (tocopherol) are the active ingredients that work to help restore normal cell metabolism that has been depleted.
Q: How is BO-SE officially described as being different from oral selenium supplements?
The product is an injection, which regulatory documents describe as bypassing the digestive process. This allows the ingredients to exert their full metabolic effects promptly on cell metabolism, unlike oral ingestion which can be affected by interference from sulfur and other digestive factors.
Q: Does BO-SE treat White Muscle Disease or is its role purely preventative?
Official indications state that the product is recommended for both the prevention and the treatment of White Muscle Disease (Selenium-Tocopherol Deficiency) syndrome.
Q: Is BO-SE classified as a vitamin supplement or a prescription drug according to regulatory sources?
The product is explicitly restricted by Federal law as a prescription drug. Its use is restricted to being by or on the order of a licensed veterinarian.
Q: What does official documentation say about the use of BO-SE in species not listed on the label?
The official label contains an important caution to use only the selenium-tocopherol product recommended for each species. This is because each specific formulation is designed for the indicated species to maximize efficacy and safety.
Q: What is the required slaughter withdrawal period for calves treated with BO-SE?
Regulatory warnings specify that use should be discontinued 30 days before treated calves are slaughtered for human consumption.
Q: What is the residue warning period for ewes, sows, and pigs after using BO-SE?
Regulatory warnings specify that use should be discontinued 14 days before treated lambs, ewes, sows, and pigs are slaughtered for human consumption.
Q: Why is a veterinary prescription legally required for BO-SE?
Federal law restricts this drug to use by or on the order of a licensed veterinarian. This restriction is based on the Federal law classification and required professional oversight for the proper, safe administration of the product.
Q: What are the key safety warnings listed on the BO-SE product information sheet?
Warnings include the risk of anaphylactoid reactions and the potential for toxicity if the preparation is improperly administered. The product is also officially contraindicated, meaning it should not be used, in pregnant ewes.
Q: Is it correct that official documents state BO-SE should not be administered to pregnant ewes?
Yes, official documents state to NOT USE IN PREGNANT EWES. Official documents include a note that deaths and abortions have been reported in pregnant ewes injected with this specific product.
Q: What kind of adverse reactions have been reported in animals after receiving BO-SE?
Reported adverse reactions listed in the official documents include acute respiratory distress, frothing from the nose and mouth, bloating, and severe depression. The product label also notes deaths and abortions in pregnant ewes have been reported.
Q: What are the described signs of a possible anaphylactoid reaction related to BO-SE warnings?
The official warnings list signs associated with reported anaphylactoid reactions, such as excitement, sweating, trembling, ataxia (loss of full control of bodily movements), respiratory distress, and cardiac dysfunction.
Q: Does the administration of BO-SE have a specific shelf life or storage requirement?
The official storage instructions state the product is to be stored at 25 C (77 F) with specific temperature excursions permitted. Official instructions specify that use should occur within 90 days of the first time the vial is punctured.
Q: What is the role of Vitamin E (tocopherol) in the BO-SE formulation, according to pharmacology?
According to the official pharmacology section, tocopherol (Vitamin E) is described as having a significant role in the oxidation process. This suggests an interrelationship with selenium in helping to restore normal cell metabolism.
Q: How is BO-SE supplied (e.g., bottle size, type of solution)?
The product is supplied as a 100 mL sterile, multiple-dose vial. It is provided ready for injection in a sterile emulsion form.
Q: Are there any specific conditions or populations that BO-SE is officially contraindicated for?
Yes, the product is officially contraindicated, meaning it should not be used, for pregnant ewes.
Q: What does the product label say about the risk of selenium toxicity from using BO-SE?
The official precautions note that selenium is toxic if administered in excess. This is the reason why regulatory documents emphasize the importance of following a fixed dose schedule.
Q: Why do official documents emphasize that a fixed dose schedule is important for selenium products?
The fixed dose schedule is emphasized because official precautions state that selenium is toxic if administered in excess.
Q: Does the label contain a high-level explanation of how BO-SE works on cell metabolism?
Yes, the label explains that when injected, the ingredients bypass the digestive process and quickly exert their full metabolic effects on cell metabolism.
Q: What are the clinical signs of White Muscle Disease that BO-SE is intended to address?
Clinical signs listed in the indications section include stiffness and lameness, diarrhea and unthriftiness (failure to thrive), and pulmonary distress and/or cardiac arrest.
Q: Does the package insert describe the use of serum levels (like SGOT) as aids in diagnosing STD?
The package insert notes that serum selenium levels, elevated SGOT, and creatine levels may serve as aids in arriving at a diagnosis of Selenium-Tocopherol Deficiency (STD), when associated with other indices.
Q: Is there research evidence supporting the use of BO-SE for prevention purposes in susceptible herds/flocks?
Yes, the official indications explicitly recommend BO-SE for the prevention and treatment of White Muscle Disease syndrome.
Q: What is 'mulberry heart disease,' which BO-SE is mentioned to help prevent in pigs?
Mulberry heart disease is mentioned in the official indications as a disease associated with Selenium-Tocopherol Deficiency in sows and weanling pigs. BO-SE is indicated as an aid in its prevention and treatment.
Q: Is it true that BO-SE use is often recommended in regions with known selenium deficiencies?
The regulatory precautions imply the product is used in such areas by noting that 'even in selenium deficient areas,' other disease conditions can produce similar clinical signs.
Q: Does the BO-SE formulation contain any preservatives, and if so, what is listed?
Yes, the official description lists 2% benzyl alcohol as a preservative within the formulation.
Q: Are there official recommendations for injecting a sow during the last week of pregnancy?
The label advises, from a prevention and control standpoint, to inject the sow during the last week of pregnancy where known deficiencies of selenium and/or vitamin E exist.
Q: Does the official labeling address why oral ingestion of selenium might be less effective than injection?
Yes, the pharmacology section explains that the presence of sulfur and possibly other factors during the digestive process can interfere with the proper utilization of orally ingested selenium and tocopherol.
Q: What is the maximum and minimum temperature recommended for storing BO-SE?
The official storage instructions state the product is to be stored at 25 C (77 F) with allowed excursions between 23 - 32 C (74 - 89 F).
Q: Are there any visual cues, like phase separation or turbidity, that indicate BO-SE should not be used?
Yes, the label advises users not to use the product if it has exhibited phase separation or turbidity (cloudiness).
Q: What is the specific chemical form of selenium used in the injection?
The official product description specifies that the selenium component used in the injection is sodium selenite.
Q: Are there any general precautions mentioned about considering other disease conditions before treating with BO-SE?
Yes, a precaution notes that other disease conditions produce similar clinical signs to the deficiency syndrome. All these conditions should be carefully considered prior to treatment.
Q: What is the significance of the term 'Rx only' on the BO-SE packaging?
The 'Rx only' designation means that Federal law restricts this drug to use by or on the order of a licensed veterinarian. It signifies the need for professional oversight.
Q: What does the label state about the need to use the product recommended for each species?
The label explicitly states: 'Use only the selenium-tocopherol product recommended for each species.' This is due to formulations being species-specific to maximize efficacy and safety.
Q: Does the formulation of BO-SE contain any polysorbates or stabilizers?
Yes, the official description lists 250 mg of polysorbate 80 per mL in the formulation.
Q: How quickly after injection is BO-SE said to exert its full metabolic effects?
The official pharmacology section indicates that when injected, the ingredients bypass the digestive process and quickly exert their full metabolic effects on cell metabolism.
Q: Why is hepatic necrosis associated with Selenium-Tocopherol Deficiency in pigs?
Hepatic necrosis (death of liver cells) is listed in the official indications as one of the diseases associated with the deficiency in sows and weanling pigs. BO-SE is indicated as an aid in its prevention and treatment.
Q: Is BO-SE indicated for use in newborn pigs?
The product label explicitly states that BO-SE is not for use in newborn pigs.
Q: Are there geographical area considerations mentioned in the dosing instructions for BO-SE?
Yes, the official dosing section for calves mentions that the required dose may depend on the severity of the condition and the geographical area.
Q: What other clinical signs of STD are listed besides stiffness and lameness?
The indications section also lists clinical signs such as diarrhea, unthriftiness (failure to thrive), and pulmonary distress and/or cardiac arrest.
Q: What are the documented adverse reactions related to depression or cardiac dysfunction?
Severe depression and cardiac dysfunction are listed as signs associated with reported adverse reactions, including anaphylactoid reactions.
Q: Is there a specific NDC number associated with the BO-SE 100 mL vial?
Yes, the official 'How Supplied' section lists the 100 mL sterile, multiple-dose vial as being associated with NDC 0061-0807-05.
Q: What is the role of sodium hydroxide or hydrochloric acid in the formula?
The official description states that sodium hydroxide and/or hydrochloric acid may be added to adjust the pH of the solution.
Q: What does 'FOR VETERINARY USE ONLY' officially signify for BO-SE buyers?
The label states this product is 'FOR VETERINARY USE ONLY.' This signifies that the drug is manufactured and legally restricted solely for use in animals.
Q: Does the product information mention any anti-inflammatory action of the ingredients?
Yes, the pharmacology section mentions that anti-inflammatory action has been demonstrated by selenium-tocopherol in certain non-clinical studies in rats.
Q: Is the term 'unthriftiness' a clinical sign of the deficiency BO-SE addresses?
Yes, unthriftiness (failure to thrive) is listed in the official indications as one of the clinical signs of White Muscle Disease (Selenium-Tocopherol Deficiency).
Q: How does BO-SE help with the signs of pulmonary distress in affected animals?
Pulmonary distress is listed as a clinical sign of the deficiency, and the product is indicated to aid in prevention/treatment by helping to restore normal cell metabolism through the injected selenium and vitamin E.
